Exane Derivatives’s TAL Education Group TAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-83
Closed -$250 913
2022
Q1
$250 Buy
+83
New +$255 ﹤0.01% 940
2021
Q4
Sell
-83
Closed -$402 965
2021
Q3
$402 Sell
83
-1,540
-95% -$13.7K ﹤0.01% 962
2021
Q2
$34.9K Buy
1,623
+719
+80% +$32.1K 0.01% 671
2021
Q1
$48.7K Hold
904
0.01% 520
2020
Q4
$64.6K Sell
904
-9,237
-91% -$666K 0.02% 439
2020
Q3
$771K Hold
10,141
0.22% 102
2020
Q2
$693K Buy
10,141
+4,649
+85% +$266K 0.19% 106
2020
Q1
$293K Sell
5,492
-6,505
-54% -$350K 0.08% 163
2019
Q4
$678K Buy
11,997
+3,299
+38% +$142K 0.13% 130
2019
Q3
$298K Buy
8,698
+2,405
+38% +$83.7K 0.05% 198
2019
Q2
$240K Buy
6,293
+6,272
+29,867% +$227K 0.04% 245
2019
Q1
$757 Sell
21
-3,086
-99% -$100K ﹤0.01% 519
2018
Q4
$82.9K Sell
3,107
-4,700
-60% -$125K 0.01% 334
2018
Q3
$203K Buy
7,807
+5,387
+223% +$174K 0.04% 241
2018
Q2
$89.2K Buy
2,420
+2,419
+241,900% +$95.1K 0.01% 348
2018
Q1
$36 Hold
1
﹤0.01% 583
2017
Q4
$30 Sell
1
-1
-50% -$30 ﹤0.01% 586
2017
Q3
$67 Sell
2
-4,804
-100% -$135K ﹤0.01% 527
2017
Q2
$98K Buy
+4,806
New +$94.4K 0.02% 272

Other funds holding TAL

Exane Derivatives's TAL Position: Q2 2022 in Review

Exane Derivatives sold out of TAL Education Group (TAL) in Q2 2022, closing a stake of 83 shares — an estimated $250 sold.

Exane Derivatives first reported a position in TAL in Q2 2017 and held it in 19 quarters. The position peaked at $771K in Q3 2020. 185 funds tracked by Wall St. Rank hold TAL as of Q2 2022.

  • Exane Derivatives reported no remaining TAL Education Group position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 83 TAL Education Group shares in Q2 2022, an estimated $250.
  • Exane Derivatives first reported a position in TAL Education Group in Q2 2017 and held it in 19 quarters.
  • Exane Derivatives's TAL Education Group position peaked at $771K in Q3 2020.
  • 185 funds tracked by Wall St. Rank held TAL Education Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.